Intro

This chapter examines the Trump administration's decision to cut $500 million in federal funding for mRNA vaccine research, as announced by Health Secretary Robert F. Kennedy Jr. An epidemiologist discusses the potential ramifications of this funding reduction on future vaccine initiatives for respiratory diseases like COVID-19 and influenza.